Covalon Technologies (OTCMKTS:CVALF – Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.06, Zacks reports. Covalon Technologies had a net margin of 12.77% and a return on equity of 15.54%. The firm had revenue of $7.07 million for the quarter, compared to analysts’ expectations of $6.65 million.
Covalon Technologies Trading Down 0.2%
CVALF stock opened at $2.12 on Friday. The firm has a market capitalization of $58.42 million, a PE ratio of 19.23 and a beta of 0.59. Covalon Technologies has a one year low of $1.16 and a one year high of $2.15. The firm has a 50-day moving average of $1.59 and a two-hundred day moving average of $1.46.
About Covalon Technologies
Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials.
The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components.
Further Reading
- Five stocks we like better than Covalon Technologies
- MarketBeat Week in Review – 08/24 – 08/28
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
